Skip to main content
Log in

Methodological Concerns of a Recent Network Meta-analysis Assessing Biologics for Eosinophilic Asthma

  • LETTER TO THE EDITOR
  • Published:
Lung Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Iftikhar IH, Schimmel M, Bender W, Swenson C, Amrol D (2018) Comparative Efficacy of Anti IL-4, IL-5 and IL-13 Drugs for treatment of eosinophilic asthma: a network meta-analysis. Lung 196(5):517–530

    Article  CAS  PubMed  Google Scholar 

  2. Chupp GL, Bradford ES, Albers FC et al (2017) Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial. Lancet Respir Med 5(5):390–400

    Article  PubMed  Google Scholar 

  3. Bel EH, Wenzel SE, Thompson PJ et al (2014) Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med 371(13):1189–1197

    Article  CAS  PubMed  Google Scholar 

  4. Castro M, Zangrilli J, Wechsler ME et al (2015) Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med 3(5):355–366

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. B. Gunsoy.

Ethics declarations

Conflict of interest

All authors are employees and own shares of GSK.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gunsoy, N.B., Bratton, D.J. & Alfonso-Cristancho, R. Methodological Concerns of a Recent Network Meta-analysis Assessing Biologics for Eosinophilic Asthma. Lung 197, 105–106 (2019). https://doi.org/10.1007/s00408-018-0183-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-018-0183-x

Navigation